Catalyst Crew Technologies Corp. (OTC: CCTC), a digital health and artificial intelligence technology company, announced the establishment of LataMed AI VE, C.A., a Venezuelan operating subsidiary intended to support its telehealth regulatory, commercialization, and healthcare deployment initiatives within Venezuela. The new entity is expected to serve as a localized operating base for the phased rollout of the Company's telehealth platform, healthcare delivery infrastructure, and regulatory progression efforts.
Management anticipates that operational activities through LataMed AI VE, C.A. may commence in the coming weeks, subject to continued regulatory progression, operational readiness, and broader commercialization planning. The subsidiary is designed to work alongside the Company's existing framework, including Inversiones Long 33, C.A., as part of a broader regional infrastructure strategy aimed at strengthening local regulatory flexibility, healthcare service operations, permit management, and long-term commercialization scalability.
According to the Company, LataMed AI VE, C.A. will support patient onboarding systems, provider coordination capabilities, telehealth infrastructure deployment, regulatory compliance procedures, commercialization planning, healthcare analytics integration, and broader operational management within its evolving Latin American healthcare ecosystem. Dr. Kevin Rodan Levy, Chief Executive Officer, stated: “The establishment of LataMed AI VE, C.A. represents an important operational milestone as we continue strengthening our localized healthcare infrastructure in Venezuela. We believe this new subsidiary will play a key role in supporting regulatory progression, commercialization readiness, and phased telehealth deployment as we move toward broader operational execution.”
The Company continues to coordinate regulatory initiatives with applicable healthcare authorities, including the Ministerio del Poder Popular para la Salud and Servicio Autonomo de Contraloría Sanitaria (SACS), while advancing broader healthcare infrastructure and commercialization objectives. Catalyst Crew is actively developing and testing its telehealth platform through its interface at https://latamedai.org.
This strategic move underscores the Company's commitment to emerging markets, with an initial emphasis on Latin America. By establishing a dedicated local subsidiary, Catalyst Crew aims to navigate the complex regulatory environment and build scalable digital health solutions. The establishment of LataMed AI VE, C.A. is a significant step toward operationalizing its telehealth platform in Venezuela, potentially improving access to healthcare services in underserved regions. The subsidiary's focus on regulatory compliance and commercialization planning is critical for long-term success in the Venezuelan market.
The implications of this announcement are substantial for the Company's growth trajectory. It demonstrates progress in executing its business strategy and may enhance investor confidence. However, as a development-stage enterprise, Catalyst Crew faces risks including the ability to secure financing, complete acquisitions, and obtain regulatory approvals. The forward-looking statements in the press release highlight these uncertainties, but the establishment of a local subsidiary is a tangible step toward realizing its vision.
For more information, visit the Company's website at https://catalystcrewai.com or review its filings with the U.S. Securities and Exchange Commission at www.sec.gov.
